Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials

Chest
Monica KhungerVamsidhar Velcheti

Abstract

Programmed death 1 (PD-1) programmed death-ligand 1 (PD-L1) inhibitors show significant clinical activity in non-small cell lung carcinoma (NSCLC). However, they are often associated with potentially fatal immune-mediated pneumonitis. Preliminary reports of trials suggest a difference in the rate of pneumonitis with PD-1 and PD-L1 inhibitors. We sought to determine the overall incidence of pneumonitis and differences according to type of inhibitors and prior chemotherapy use. MEDLINE, Embase, and Scopus databases were searched up to November 2016. Rates of pneumonitis of any grade and grade ≥ 3 from all clinical trials investigating nivolumab, pembrolizumab, atezolizumab, durvalumab, and avelumab as single agents in NSCLC were collected. The incidence of pneumonitis across trials was calculated using DerSimonian-Laird random effects models. We compared incidences between PD-1 and PD-L1 inhibitors and between treatment naive and previously treated patients. Nineteen trials (12 with PD-1 inhibitors [n = 3,232] and 7 with PD-L1 inhibitors [n = 1,806]) were identified. PD-1 inhibitors were found to have statistically significant higher incidence of any grade pneumonitis compared with PD-L1 inhibitors (3.6%; 95% CI, 2.4%-4.9% vs 1.3...Continue Reading

Citations

Feb 15, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerUNKNOWN National Comprehensive Cancer Network
Nov 23, 2017·Journal for Immunotherapy of Cancer·I PuzanovUNKNOWN Society for Immunotherapy of Cancer Toxicity Management Working Group
Dec 3, 2017·Journal of Hematology & Oncology·Bingshan LiuDelong Liu
Jul 12, 2018·British Journal of Hospital Medicine·Benjamin A Pickwell-SmithRuth E Board
Oct 12, 2018·BMJ Case Reports·Neal AndruskaVishesh Paul
Nov 21, 2018·Radiology·Mizuki NishinoF Stephen Hodi
Dec 24, 2018·Expert Review of Anticancer Therapy·Barouyr BaroudjianUNKNOWN PATIO group
Mar 14, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·John A ThompsonJillian L Scavone
May 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yanwen ZhongKejiang Lin
Oct 11, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Jacques CadranelVincent Fallet
Mar 14, 2019·Current Drug Safety·Maurizio MarvisiChiara Mancini
Jul 17, 2019·The Journal of Clinical Investigation·Karthik SureshFranco D'Alessio
Dec 6, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Chong-Kin Liam
Dec 5, 2017·Journal of Immunotherapy·Farkhad ManapovChukwuka Eze
Jan 17, 2020·CA: a Cancer Journal for Clinicians·Lucy Boyce Kennedy, April K S Salama
Mar 23, 2019·The Oncologist·Vanessa A Reed, Naiyer Rizvi
Aug 16, 2019·Critical Care Medicine·Karthik Suresh, Franco D'Alessio
Apr 19, 2020·Journal for Immunotherapy of Cancer·Patrick BolandSabina Sandigursky
Jun 5, 2019·The American Journal of Surgical Pathology·Brandon T LarsenAnja C Roden
May 17, 2019·Nature Reviews. Clinical Oncology·Filipe MartinsMichel Obeid
May 19, 2020·American Society of Clinical Oncology Educational Book·Carey K AndersAlexandra Thomas
Jul 31, 2020·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kathryn Long, Karthik Suresh
Jul 3, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·X LinC Zhou
Aug 11, 2020·Expert Review of Clinical Immunology·Sandra G WilliamsSarthak Gupta
Sep 17, 2020·Case Reports in Oncological Medicine·Amanda RamosOladapo Yeku

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.